Shengule, S.; Alai, S.; Bhandare, S.; Patil, S.; Gautam, M.; Mangaonkar, B.; Gupta, S.; Shaligram, U.; Gairola, S.
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases. Vaccines 2024, 12, 433.
https://doi.org/10.3390/vaccines12040433
AMA Style
Shengule S, Alai S, Bhandare S, Patil S, Gautam M, Mangaonkar B, Gupta S, Shaligram U, Gairola S.
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases. Vaccines. 2024; 12(4):433.
https://doi.org/10.3390/vaccines12040433
Chicago/Turabian Style
Shengule, Sushant, Shweta Alai, Sachin Bhandare, Sumant Patil, Manish Gautam, Bhushan Mangaonkar, Sumit Gupta, Umesh Shaligram, and Sunil Gairola.
2024. "Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases" Vaccines 12, no. 4: 433.
https://doi.org/10.3390/vaccines12040433
APA Style
Shengule, S., Alai, S., Bhandare, S., Patil, S., Gautam, M., Mangaonkar, B., Gupta, S., Shaligram, U., & Gairola, S.
(2024). Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases. Vaccines, 12(4), 433.
https://doi.org/10.3390/vaccines12040433
